HUP0200663A2 - Novel method for producing doxazosin mesylate in a crystalline modification designated as form a - Google Patents
Novel method for producing doxazosin mesylate in a crystalline modification designated as form aInfo
- Publication number
- HUP0200663A2 HUP0200663A2 HU0200663A HUP0200663A HUP0200663A2 HU P0200663 A2 HUP0200663 A2 HU P0200663A2 HU 0200663 A HU0200663 A HU 0200663A HU P0200663 A HUP0200663 A HU P0200663A HU P0200663 A2 HUP0200663 A2 HU P0200663A2
- Authority
- HU
- Hungary
- Prior art keywords
- novel method
- crystalline modification
- doxazosin mesylate
- modification designated
- producing
- Prior art date
Links
- 229960000220 doxazosin mesylate Drugs 0.000 title 1
- VJECBOKJABCYMF-UHFFFAOYSA-N doxazosin mesylate Chemical compound [H+].CS([O-])(=O)=O.C1OC2=CC=CC=C2OC1C(=O)N(CC1)CCN1C1=NC(N)=C(C=C(C(OC)=C2)OC)C2=N1 VJECBOKJABCYMF-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19912063A DE19912063A1 (en) | 1999-03-18 | 1999-03-18 | New process for the preparation of doxazosin mesylate in a crystal modification called Form A. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0200663A2 true HUP0200663A2 (en) | 2002-08-28 |
Family
ID=7901411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200663A HUP0200663A2 (en) | 1999-03-18 | 2000-03-06 | Novel method for producing doxazosin mesylate in a crystalline modification designated as form a |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1165548A1 (en) |
| JP (1) | JP2002540109A (en) |
| KR (1) | KR20010113753A (en) |
| CN (1) | CN1352643A (en) |
| AU (1) | AU3960800A (en) |
| CA (1) | CA2367903A1 (en) |
| CZ (1) | CZ20013347A3 (en) |
| DE (1) | DE19912063A1 (en) |
| HU (1) | HUP0200663A2 (en) |
| IL (1) | IL144944A0 (en) |
| PL (1) | PL350088A1 (en) |
| TR (1) | TR200102730T2 (en) |
| WO (1) | WO2000056731A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19912573A1 (en) * | 1999-03-19 | 2000-09-21 | Knoll Ag | Medicament containing doxazosin mesylate of crystal modification D |
| CA2706372A1 (en) | 2007-12-24 | 2009-07-02 | Cipla Limited | Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof |
| CN109988158A (en) * | 2018-01-03 | 2019-07-09 | 合肥立方制药股份有限公司 | X crystal form, doxazosin mesylate containing X crystal form and its preparation method and application |
| CN111303130B (en) * | 2018-12-11 | 2021-09-14 | 合肥立方制药股份有限公司 | Doxazosin mesylate crystal form, and preparation method and application thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1287588B1 (en) * | 1996-12-13 | 1998-08-06 | Alfa Chem Ital | CRYSTALLINE FORM OF MESILATE DOXAZOSIN AND PROCESS FOR ITS PRODUCTION |
| PT849266E (en) * | 1996-12-20 | 2007-03-30 | Heumann Pcs Gmbh | Novel polymorphic form of doxazosin mesylate (form iii) |
| DE19800214A1 (en) * | 1998-01-06 | 1999-07-15 | Knoll Ag | Process for the preparation of doxazosin mcsylate in a crystal modification referred to as Form A and an intermediate therefor |
-
1999
- 1999-03-18 DE DE19912063A patent/DE19912063A1/en not_active Withdrawn
-
2000
- 2000-03-06 PL PL00350088A patent/PL350088A1/en unknown
- 2000-03-06 JP JP2000606592A patent/JP2002540109A/en active Pending
- 2000-03-06 HU HU0200663A patent/HUP0200663A2/en unknown
- 2000-03-06 TR TR2001/02730T patent/TR200102730T2/en unknown
- 2000-03-06 WO PCT/EP2000/001939 patent/WO2000056731A1/en not_active Application Discontinuation
- 2000-03-06 CZ CZ20013347A patent/CZ20013347A3/en unknown
- 2000-03-06 AU AU39608/00A patent/AU3960800A/en not_active Abandoned
- 2000-03-06 IL IL14494400A patent/IL144944A0/en unknown
- 2000-03-06 KR KR1020017011780A patent/KR20010113753A/en not_active Application Discontinuation
- 2000-03-06 CA CA002367903A patent/CA2367903A1/en not_active Abandoned
- 2000-03-06 CN CN00805209A patent/CN1352643A/en active Pending
- 2000-03-06 EP EP00918763A patent/EP1165548A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| PL350088A1 (en) | 2002-11-04 |
| KR20010113753A (en) | 2001-12-28 |
| EP1165548A1 (en) | 2002-01-02 |
| TR200102730T2 (en) | 2002-06-21 |
| CZ20013347A3 (en) | 2002-01-16 |
| JP2002540109A (en) | 2002-11-26 |
| DE19912063A1 (en) | 2000-09-21 |
| IL144944A0 (en) | 2002-06-30 |
| WO2000056731A1 (en) | 2000-09-28 |
| AU3960800A (en) | 2000-10-09 |
| CN1352643A (en) | 2002-06-05 |
| CA2367903A1 (en) | 2000-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24141A (en) | Method for preparing a composition | |
| HUP0105211A3 (en) | Method for producing chlorine | |
| EG23017A (en) | Method for producing brushware | |
| IL140079A0 (en) | Process for producing bisphennol a | |
| PL348858A1 (en) | Method for producing l-phenylephrine hydrochloride | |
| PL361146A1 (en) | Method for producing isocyanato-organosilanes | |
| HUP0102967A3 (en) | Method for producing organosilylalkyl-polysulphanes | |
| HUP0200663A2 (en) | Novel method for producing doxazosin mesylate in a crystalline modification designated as form a | |
| IL144264A0 (en) | Process for producing quinolinecarbaldehyde | |
| AU2645900A (en) | Method for producing a vwf preparation | |
| GB2363379B (en) | Process for producing alpha-aminoketones | |
| IL144651A0 (en) | Method for producing l-sorbose | |
| IL154825A0 (en) | A METHOD FOR PRODUCING Delta1-PYRROLINES | |
| AU4273501A (en) | Process for producing camptothecin | |
| IL146573A0 (en) | Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones | |
| AU7265900A (en) | Method for producing otoplastics | |
| HUP0203482A3 (en) | Method for producing o-chloromethyl benzenecarbonyl chlorides | |
| IL147804A0 (en) | Method for producing 4-cyano-2-aminomethylthiazol | |
| IL147769A0 (en) | Method for producing 2-aminomethyl-4-cyano-thiazol | |
| EP1304344A4 (en) | Method for producing polycarbonate | |
| AU8444201A (en) | Process for producing fluoroalkanol | |
| AU2003213254A1 (en) | Method for producing a nonwoven fabric with enhanced characteristics | |
| HUP0200455A3 (en) | Method for producing 4-amino-5-chloro-1-phenyl pyridazinone-(6) | |
| AU2001263765A1 (en) | Method for producing a nonwoven | |
| SG99292A1 (en) | A method for producing oxide compounds |